Retinal dysfunction in Parkinson's disease-results of the extended protocol for photopic negative response (PHNR) full-field electroretinogram (ERG).
ERG
Electroretinography
Optical coherence tomography
Parkinson’s disease
Photopic negative response
Journal
Documenta ophthalmologica. Advances in ophthalmology
ISSN: 1573-2622
Titre abrégé: Doc Ophthalmol
Pays: Netherlands
ID NLM: 0370667
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
30
11
2022
accepted:
06
07
2023
medline:
1
9
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
ppublish
Résumé
We investigated whether the photopic negative response (PhNR) in the electroretinogram (ERG) was affected in Parkinson's disease (PD) patients and whether it was associated with retinal changes on optical coherence tomography (OCT). Thirty-two patients with PD and 31 age and sex-matched healthy controls from a single tertiary centre were included in the study. Hoehn and Yahr scale scores and the presence of REM sleep behaviour were recorded. PhNR, a-wave and b-wave responses in photopic ERG (red on blue background) and retinal layer thicknesses in OCT were obtained. The mean age was 61 ± 10.4 in the PD group (female/male: 18/14) and 60.9 ± 7 in the control group (female/male: 18/13). The amplitudes of the PhNR, a- and b-waves in the ERG were significantly decreased in the PD group, but the implicit times were not significantly different. BCVA was significantly correlated with Hoehn and Yahr scores (p < 0.001, r = - 0.596). There was a significant correlation between BCVA and a-wave amplitude (p = 0.047, r = - 0.251). On OCT analysis, the thickness of the nasal INL was increased, and the temporal and inferior OPL and temporal peripapillary RNFL were decreased in the PD group compared to healthy controls (p = 0.032, p = 0.002, p = 0.016 and p = 0.012, respectively). This study demonstrated reduced a-wave, b-wave and PhNR-wave amplitudes on ERG measurements in PD patients. These findings suggest that the whole ERG response, not just the PhNR, is attenuated in patient with PD, suggesting a possible involvement of the visual system in the disease.
Sections du résumé
BACKGROUND
We investigated whether the photopic negative response (PhNR) in the electroretinogram (ERG) was affected in Parkinson's disease (PD) patients and whether it was associated with retinal changes on optical coherence tomography (OCT).
METHODS
Thirty-two patients with PD and 31 age and sex-matched healthy controls from a single tertiary centre were included in the study. Hoehn and Yahr scale scores and the presence of REM sleep behaviour were recorded. PhNR, a-wave and b-wave responses in photopic ERG (red on blue background) and retinal layer thicknesses in OCT were obtained.
RESULTS
The mean age was 61 ± 10.4 in the PD group (female/male: 18/14) and 60.9 ± 7 in the control group (female/male: 18/13). The amplitudes of the PhNR, a- and b-waves in the ERG were significantly decreased in the PD group, but the implicit times were not significantly different. BCVA was significantly correlated with Hoehn and Yahr scores (p < 0.001, r = - 0.596). There was a significant correlation between BCVA and a-wave amplitude (p = 0.047, r = - 0.251). On OCT analysis, the thickness of the nasal INL was increased, and the temporal and inferior OPL and temporal peripapillary RNFL were decreased in the PD group compared to healthy controls (p = 0.032, p = 0.002, p = 0.016 and p = 0.012, respectively).
CONCLUSION
This study demonstrated reduced a-wave, b-wave and PhNR-wave amplitudes on ERG measurements in PD patients. These findings suggest that the whole ERG response, not just the PhNR, is attenuated in patient with PD, suggesting a possible involvement of the visual system in the disease.
Identifiants
pubmed: 37515709
doi: 10.1007/s10633-023-09945-8
pii: 10.1007/s10633-023-09945-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
89-98Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Chrysou A, Jansonius NM, van Laar T (2019) Retinal layers in Parkinson’s disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord 64:40–49. https://doi.org/10.1016/j.parkreldis.2019.04.023
doi: 10.1016/j.parkreldis.2019.04.023
pubmed: 31054866
Ahn J, Lee JY, Kim TW, Yoon EJ, Oh S, Kim YK et al (2018) Retinal thinning associates with Nigral dopaminergic loss in de novo Parkinson disease. Neurology 91(11):e1003–e1012. https://doi.org/10.1212/WNL.0000000000006157
doi: 10.1212/WNL.0000000000006157
pubmed: 30111550
Satue M, Rodrigo MJ, Obis J, Vilades E, Gracia H, Otin S et al (2017) Evaluation of progressive visual dysfunction and retinal degeneration in patients with Parkinson’s disease. Invest Ophthalmol Vis Sci 58(2):1151–1157. https://doi.org/10.1167/iovs.16-20460
doi: 10.1167/iovs.16-20460
pubmed: 28208185
Kaur M, Saxena R, Singh D, Behari M, Sharma P, Menon V (2015) Correlation between structural and functional retinal changes in Parkinson disease. J Neuroophthalmol 35(3):254–258. https://doi.org/10.1097/WNO.0000000000000240
doi: 10.1097/WNO.0000000000000240
pubmed: 25807477
Ortuno-Lizaran I, Sanchez-Saez X, Lax P, Serrano GE, Beach TG, Adler CH et al (2020) Dopaminergic retinal cell loss and visual dysfunction in Parkinson disease. Ann Neurol 88(5):893–906. https://doi.org/10.1002/ana.25897
doi: 10.1002/ana.25897
pubmed: 32881029
pmcid: 10005860
Ortuno-Lizaran I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N (2018) Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson’s disease pathology severity. Mov Disord 33(8):1315–1324. https://doi.org/10.1002/mds.27392
doi: 10.1002/mds.27392
pubmed: 29737566
pmcid: 6146055
Veys L, Vandenabeele M, Ortuno-Lizaran I, Baekelandt V, Cuenca N, Moons L et al (2019) Retinal alpha-synuclein deposits in Parkinson’s disease patients and animal models. Acta Neuropathol 137(3):379–395. https://doi.org/10.1007/s00401-018-01956-z
doi: 10.1007/s00401-018-01956-z
pubmed: 30721408
La Morgia C, Di Vito L, Carelli V, Carbonelli M (2017) Patterns of retinal ganglion cell damage in neurodegenerative disorders: parvocellular vs magnocellular degeneration in optical coherence tomography studies. Front Neurol 8:710. https://doi.org/10.3389/fneur.2017.00710
doi: 10.3389/fneur.2017.00710
pubmed: 29312131
pmcid: 5744067
Huang L, Wang C, Wang W, Wang Y, Zhang R (2021) The specific pattern of retinal nerve fiber layer thinning in Parkinson’s disease: a systematic review and meta-analysis. J Neurol 268(11):4023–4032. https://doi.org/10.1007/s00415-020-10094-0
doi: 10.1007/s00415-020-10094-0
pubmed: 32691237
Ucak T, Alagoz A, Cakir B, Celik E, Bozkurt E, Alagoz G (2016) Analysis of the retinal nerve fiber and ganglion cell—inner plexiform layer by optical coherence tomography in Parkinson’s patients. Parkinsonism Relat Disord 31:59–64. https://doi.org/10.1016/j.parkreldis.2016.07.004
doi: 10.1016/j.parkreldis.2016.07.004
pubmed: 27423922
Tagliati M, Bodis-Wollner I, Yahr MD (1996) The pattern electroretinogram in Parkinson’s disease reveals lack of retinal spatial tuning. Electroencephalograph Clin Neurophysiol/Evoked Potentials Section 100(1):1–11. https://doi.org/10.1016/0168-5597(95)00169-7
doi: 10.1016/0168-5597(95)00169-7
Peppe A, Stanzione P, Pierelli F, De Angelis D, Pierantozzi M, Bernardi G (1995) Visual alterations in de novo Parkinson’s disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials. Neurology 45(6):1144–1148. https://doi.org/10.1212/wnl.45.6.1144
doi: 10.1212/wnl.45.6.1144
pubmed: 7783879
Rangaswamy NV, Shirato S, Kaneko M, Digby BI, Robson JG, Frishman LJ (2007) Effects of spectral characteristics of ganzfeld stimuli on the photopic negative response (PhNR) of the ERG. Invest Ophthalmol Vis Sci 48(10):4818–4828. https://doi.org/10.1167/iovs.07-0218
doi: 10.1167/iovs.07-0218
pubmed: 17898309
Frishman L, Sustar M, Kremers J, McAnany JJ, Sarossy M, Tzekov R et al (2018) ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc Ophthalmol 136(3):207–211. https://doi.org/10.1007/s10633-018-9638-x
doi: 10.1007/s10633-018-9638-x
pubmed: 29855761
pmcid: 6061118
Asanad S, Felix CM, Fantini M, Harrington MG, Sadun AA, Karanjia R (2021) Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature. Sci Rep 11(1):6344. https://doi.org/10.1038/s41598-021-85010-1
doi: 10.1038/s41598-021-85010-1
pubmed: 33737516
pmcid: 7973731
Moss HE, Park JC, McAnany JJ (2015) The photopic negative response in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 56(6):3709–3714. https://doi.org/10.1167/iovs.15-16586
doi: 10.1167/iovs.15-16586
pubmed: 26047172
pmcid: 4466812
Machida S (2012) Clinical applications of the photopic negative response to optic nerve and retinal diseases. J Ophthalmol. https://doi.org/10.1155/2012/397178
doi: 10.1155/2012/397178
pubmed: 23133741
pmcid: 3486014
Gotoh Y, Machida S, Tazawa Y (2004) Selective loss of the photopic negative response in patients with opticnerve atrophy. Arch Ophthalmol 122(3):341–346. https://doi.org/10.1001/archopht.122.3.341
doi: 10.1001/archopht.122.3.341
pubmed: 15006846
Ortuno-Lizaran I, Esquiva G, Beach TG, Serrano GE, Adler CH, Lax P et al (2018) Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson’s disease. Acta Neuropathol Commun 6(1):90. https://doi.org/10.1186/s40478-018-0596-z
doi: 10.1186/s40478-018-0596-z
pubmed: 30201049
pmcid: 6130068
Diaconu S, Falup-Pecurariu O, Tint D, Falup-Pecurariu C (2021) REM sleep behaviour disorder in Parkinson’s disease (review). Exp Ther Med 22(2):812. https://doi.org/10.3892/etm.2021.10244
doi: 10.3892/etm.2021.10244
pubmed: 34131435
pmcid: 8193212
Zhang X, Sun X, Wang J, Tang L, Xie A (2017) Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson’s disease: a meta and meta-regression analysis. Neurol Sci 38(1):163–170. https://doi.org/10.1007/s10072-016-2744-1
doi: 10.1007/s10072-016-2744-1
pubmed: 27770275
Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C (2011) Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 77(11):1048–1054. https://doi.org/10.1212/WNL.0b013e31822e560e
doi: 10.1212/WNL.0b013e31822e560e
pubmed: 21832215
Plazzi G (2004) REM sleep behavior disorders in Parkinson’s disease and other Parkinsonian disorders. Sleep Med 5(2):195–199. https://doi.org/10.1016/j.sleep.2004.01.003
doi: 10.1016/j.sleep.2004.01.003
pubmed: 15033143
Bhidayasiri R, Tarsy D. Parkinson’s disease: Hoehn and Yahr scale. Movement disorders: a video Atlas. Springer; 2012. p. 4–5. https://doi.org/10.1007/978-1-60327-426-5_2
Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH (2007) The REM sleep behavior disorder screening questionnaire–a new diagnostic instrument. Mov Disord 22(16):2386–2393. https://doi.org/10.1002/mds.21740
doi: 10.1002/mds.21740
pubmed: 17894337
Rufiange M, Dumont M, Lachapelle P (2005) Modulation of the human photopic ERG luminance-response function with the use of chromatic stimuli. Vision Res 45(17):2321–2330. https://doi.org/10.1016/j.visres.2005.02.010
doi: 10.1016/j.visres.2005.02.010
pubmed: 15924945
Prencipe M, Perossini T, Brancoli G, Perossini M (2020) The photopic negative response (PhNR): measurement approaches and utility in glaucoma. Int Ophthalmol 40(12):3565–3576. https://doi.org/10.1007/s10792-020-01515-0
doi: 10.1007/s10792-020-01515-0
pubmed: 32737731
pmcid: 7669808
Armstrong RA (2011) Visual symptoms in Parkinson’s disease. Parkinsons Dis. https://doi.org/10.4061/2011/908306
doi: 10.4061/2011/908306
pubmed: 21687773
pmcid: 3109513
Silverstein SM, Demmin DL, Schallek JB, Fradkin SI (2020) Measures of retinal structure and function as biomarkers in neurology and psychiatry. Biomark Neuropsych 2:100018. https://doi.org/10.1016/j.bionps.2020.100018
doi: 10.1016/j.bionps.2020.100018
Nowacka B, Lubinski W, Honczarenko K, Potemkowski A, Safranow K (2015) Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson’s disease (PD). Doc Ophthalmol 131(2):95–104. https://doi.org/10.1007/s10633-015-9503-0
doi: 10.1007/s10633-015-9503-0
pubmed: 25972299
pmcid: 4567588
Nguyen-Legros J, Versaux-Botteri C, Vernier P (1999) Dopamine receptor localization in the mammalian retina. Mol Neurobiol 19(3):181–204. https://doi.org/10.1007/BF02821713
doi: 10.1007/BF02821713
pubmed: 10495103
Nowacka B, Lubiński W, Honczarenko K, Potemkowski A, Safranow K (2015) Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson’s disease (PD). Doc Ophthalmol 131(2):95–104. https://doi.org/10.1007/s10633-015-9503-0
doi: 10.1007/s10633-015-9503-0
pubmed: 25972299
pmcid: 4567588
Ikeda H, Head G, Ellis CK (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson’s disease and a follow up study. Vision Res 34(19):2629–2638. https://doi.org/10.1016/0042-6989(94)90248-8
doi: 10.1016/0042-6989(94)90248-8
pubmed: 7975301
Mello LGM, Paraguay IBB, Andrade TS, Rocha A, Barbosa ER, Oyamada MK et al (2022) Electroretinography reveals retinal dysfunction in Parkinson’s disease despite normal high-resolution optical coherence tomography findings. Parkinsonism Relat Disord 101:90–95. https://doi.org/10.1016/j.parkreldis.2022.06.018
doi: 10.1016/j.parkreldis.2022.06.018
pubmed: 35810523
Polo V, Satue M, Rodrigo MJ, Otin S, Alarcia R, Bambo MP et al (2016) Visual dysfunction and its correlation with retinal changes in patients with Parkinson’s disease: an observational cross-sectional study. BMJ Open 6(5):58. https://doi.org/10.1136/bmjopen-2015-009658
doi: 10.1136/bmjopen-2015-009658
Huang L, Zhang D, Ji J, Wang Y, Zhang R (2021) Central retina changes in Parkinson’s disease: a systematic review and meta-analysis. J Neurol 268(12):4646–4654. https://doi.org/10.1007/s00415-020-10304-9
doi: 10.1007/s00415-020-10304-9
pubmed: 33174132
Zhou WC, Tao JX, Li J (2021) Optical coherence tomography measurements as potential imaging biomarkers for Parkinson’s disease: A systematic review and meta-analysis. Eur J Neurol 28(3):763–774. https://doi.org/10.1111/ene.14613
doi: 10.1111/ene.14613
pubmed: 33107159
Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R et al (2014) Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration. Am J Ophthalmol 157(2):470–8 e2. https://doi.org/10.1016/j.ajo.2013.09.028
doi: 10.1016/j.ajo.2013.09.028
Albrecht P, Muller AK, Sudmeyer M, Ferrea S, Ringelstein M, Cohn E et al (2012) Optical coherence tomography in parkinsonian syndromes. PLoS ONE 7(4):e34891. https://doi.org/10.1371/journal.pone.0034891
doi: 10.1371/journal.pone.0034891
pubmed: 22514688
pmcid: 3325949
Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S (2014) alpha-synuclein in the inner retina in parkinson disease. Ann Neurol 75(6):964–966. https://doi.org/10.1002/ana.24182
doi: 10.1002/ana.24182
pubmed: 24816946
Breen DP, Vuono R, Nawarathna U, Fisher K, Shneerson JM, Reddy AB et al (2014) Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol 71(5):589–595. https://doi.org/10.1001/jamaneurol.2014.65
doi: 10.1001/jamaneurol.2014.65
pubmed: 24687146
pmcid: 4119609
Joyce DS, Feigl B, Kerr G, Roeder L, Zele AJ (2018) Melanopsin-mediated pupil function is impaired in Parkinson’s disease. Sci Rep 8(1):7796. https://doi.org/10.1038/s41598-018-26078-0
doi: 10.1038/s41598-018-26078-0
pubmed: 29773814
pmcid: 5958070
Provencio I, Rodriguez IR, Jiang G, Hayes WP, Moreira EF, Rollag MD (2000) A novel human opsin in the inner retina. J Neurosci 20(2):600–605. https://doi.org/10.1523/JNEUROSCI.20-02-00600.2000
doi: 10.1523/JNEUROSCI.20-02-00600.2000
pubmed: 10632589
pmcid: 6772411
Ostrin LA, Strang CE, Chang K, Jnawali A, Hung LF, Arumugam B et al (2018) Immunotoxin-induced ablation of the intrinsically photosensitive retinal ganglion cells in rhesus monkeys. Front Neurol 9:1000. https://doi.org/10.3389/fneur.2018.01000
doi: 10.3389/fneur.2018.01000
pubmed: 30542318
pmcid: 6277788
Mandrekar JN (2010) Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 5(9):1315–1316. https://doi.org/10.1097/JTO.0b013e3181ec173d
doi: 10.1097/JTO.0b013e3181ec173d
pubmed: 20736804
Popova E (2014) Role of dopamine in distal retina. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 200(5):333–358. https://doi.org/10.1007/s00359-014-0906-2
doi: 10.1007/s00359-014-0906-2
pubmed: 24728309
Popova E, Kostov M, Kupenova P (2016) Effects of dopamine D(1) receptor blockade on the ERG b- and d-waves during blockade of ionotropic GABA receptors. Eye Vis 3:32. https://doi.org/10.1186/s40662-016-0064-4
doi: 10.1186/s40662-016-0064-4
Ikeda H, Head GM, Ellis CJ (1994) Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson’s disease and a follow up study. Vis Res 34(19):2629–2638. https://doi.org/10.1016/0042-6989(94)90248-8
doi: 10.1016/0042-6989(94)90248-8
pubmed: 7975301